Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
VP35 is a multifunctional protein encoded by the Zaire ebolavirus (EBOV). It plays essential roles in both viral replication and immune evasion, making it a critical factor for EBOV pathogenicity. VP35 acts as an essential cofactor for the viral RNA-dependent RNA polymerase complex, required for efficient transcription and replication of the viral genome. VP35 suppresses host innate immune responses by multiple mechanisms including inhibiting production of type I interferons (IFN-α/β), binding double-stranded RNA (dsRNA) shielding it from detection by host sensors, and blocking phosphorylation and activation of interferon regulatory factor 3 (IRF3).
Disrupting either function (polymerase cofactor activity or immune evasion) could significantly impair EBOV replication or enhance host clearance mechanisms
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zaire ebolavirus Polymerase Cofactor VP35 (VP35).